Outpatient parenteral antimicrobial therapy for osteomyelitis

被引:28
作者
Tice, AD
机构
[1] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
[2] Infect Ltd PS, Tacoma, WA USA
关键词
D O I
10.1016/S0891-5520(05)70027-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Osteomyelitis is an excellent example of an infection that can benefit from outpatient parenteral antimicrobial therapy. Most cases require a prolonged course of intravenous antimicrobial therapy although the patient may be well otherwise. Although the spectrum of organisms and related diseases is great, antimicrobial can be selected and used to meet the needs of almost any situation. For osteomyelitis, there must often be special considerations in regard to patient selection, delivery model, vascular access, infusion device, surgery, and other diseases that may play an important role.
引用
收藏
页码:903 / +
页数:19
相关论文
共 75 条
[1]  
*AM HOSP ASS, 1998, HOSP STAT
[2]  
BALINSKY W, 1989, AM J MED, V87, P301, DOI 10.1016/S0002-9343(89)80155-X
[3]   FURTHER OBSERVATIONS ON VALUE OF ORAL PENICILLINS IN CHRONIC STAPHYLOCOCCAL OSTEOMYELITIS [J].
BELL, SM .
MEDICAL JOURNAL OF AUSTRALIA, 1976, 2 (16) :591-593
[4]   The home infusion therapy relative benefit index - Summary of an analysis using insurance claims data [J].
Birnbaum, HG ;
Tang, M .
MEDICAL CARE, 1998, 36 (05) :757-765
[5]  
BRAUSE BD, 1995, PRINCIPLES PRACTICE, P1051
[6]  
BUCHHOLZ HW, 1984, CLIN ORTHOP RELAT R, V190, P96
[7]  
BUTT WP, 1973, CLIN ORTHOP RELAT R, V96, P20
[8]   COST-ANALYSIS OF A HOME INTRAVENOUS ANTIBIOTIC PROGRAM [J].
CHAMBERLAIN, TM ;
LEHMAN, ME ;
GROH, MJ ;
MUNROE, WP ;
REINDERS, TP .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1988, 45 (11) :2341-2345
[9]  
Cierny G, 1985, CONT ORTHOP, V10, P17, DOI DOI 10.1097/01.BLO.0000088564.81746.62
[10]   ORAL CIPROFLOXACIN TREATMENT OF PSEUDOMONAS-AERUGINOSA OSTEOMYELITIS [J].
DAN, M ;
SIEGMANIGRA, Y ;
PITLIK, S ;
RAZ, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (05) :849-852